Projects per year
Personal profile
Headline
Research Scientist PROFESSOR | Psychiatry
Biography
Dr. Jeremy M. Silverman is a Professor in the Department of Psychiatry at the Mount Sinai School of Medicine and the Director of the Mount Sinai Family Studies Research Center which he established in 1988. He received his B.A. from Oberlin College (1978) and his Ph.D. in clinical psychology from New York University (1987). He joined the Psychiatry Department faculty at Mount Sinai in 1987. Dr. Silverman's major research interests pertain to the genetics of psychiatric disorders and, more specifically, the improved delineation of phenotypes and endophenotypes (intermediate phenotypes) associated with successful cognitive aging, dementia, schizophrenia, and other neuropsychiatric conditions in order to strengthen gene finding strategies. Dr. Silverman is also interested in the identification of non-genetic risk and protective factors associated with these conditions. Multi-Disciplinary Training Area Neuroscience [NEU] Education BA, Oberlin College PhD, New York University MA, New York University
Fingerprint
Dive into the research topics where Jeremy Silverman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 21 Finished
-
Computerized Cognitive Training to Improve Cognition in Diabetic Elderly Veterans
U.S. Department of Veterans Affairs
1/04/14 → 30/09/20
Project: Research
-
COMPUTERIZED COGNITIVE TRAINING TO IMPROVE COGNITION IN DIABETIC ELDERLY VETERANS
U.S. Department of Veterans Affairs
1/04/14 → 30/09/19
Project: Research
-
COMPUTERIZED COGNITIVE TRAINING TO IMPROVE COGNITION IN DIABETIC ELDERLY VETERANS
U.S. Department of Veterans Affairs
1/04/14 → 30/09/19
Project: Research
-
COMPUTERIZED COGNITIVE TRAINING TO IMPROVE COGNITION IN DIABETIC ELDERLY VETERANS
U.S. Department of Veterans Affairs
1/04/14 → 30/09/19
Project: Research
-
COMPUTERIZED COGNITIVE TRAINING TO IMPROVE COGNITION IN DIABETIC ELDERLY VETERANS
U.S. Department of Veterans Affairs
1/04/14 → 30/09/19
Project: Research
-
Does computerized cognitive training improve diabetes self-management and cognition? A randomized control trial of middle-aged and older veterans with type 2 diabetes
Silverman, J. M., Zhu, C. W., Schmeidler, J., Lee, P. G., Alexander, N. B., Guerrero-Berroa, E., Beeri, M. S., West, R. K., Sano, M., Nabozny, M. & Karran, M., Jan 2023, In: Diabetes Research and Clinical Practice. 195, 110149.Research output: Contribution to journal › Article › peer-review
-
A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts
Schizophrenia Working Group of the Psychiatric Genomics Consortium & Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, 1 Nov 2021, In: Biological Psychiatry. 90, 9, p. 611-620 10 p.Research output: Contribution to journal › Article › peer-review
35 Scopus citations -
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
Joshi, Y. B., Thomas, M. L., Braff, D. L., Green, M. F., Gur, R. C., Gur, R. E., Nuechterlein, K. H., Stone, W. S., Greenwood, T. A., Lazzeroni, L. C., MacDonald, L. R., Molina, J. L., Nungaray, J. A., Radant, A. D., Silverman, J. M., Sprock, J., Sugar, C. A., Tsuang, D. W., Tsuang, M. T., Turetsky, B. I., & 2 others, 1 Sep 2021, In: American Journal of Psychiatry. 178, 9, p. 838-847 10 p.Research output: Contribution to journal › Article › peer-review
32 Scopus citations -
A polygenic resilience score moderates the genetic risk for schizophrenia
The Schizophrenia Working Group of the Psychiatric Genomics Consortium & Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), 1 Mar 2021, In: Molecular Psychiatry. 26, 3, p. 800-815 16 p.Research output: Contribution to journal › Article › peer-review
Open Access24 Scopus citations -
Genome-wide DNA methylation profiling in nonagenarians suggests an effect of PM20D1 in late onset Alzheimer's disease
Coto-Vílchez, C., Martínez-Magaña, J. J., Mora-Villalobos, L., Valerio, D., Genis-Mendoza, A. D., Silverman, J. M., Nicolini, H., Raventós, H. & Chavarria-Soley, G., 2021, (Accepted/In press) In: CNS Spectrums.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Press/Media
-
Commonly used drugs for schizophrenia linked to greater cognitive impairment
17/05/21 → 18/05/21
3 items of Media coverage
Press/Media
-
COMMONLY USED DRUGS FOR SCHIZOPHRENIA LINKED TO GREATER COGNITIVE IMPAIRMENT
17/05/21
1 item of Media coverage
Press/Media
-
Commonly Used Drugs for Schizophrenia Linked to Greater Cognitive Impairment
17/05/21
1 item of Media coverage
Press/Media
-